Serum pro-surfactant protein B is correlated with clinical properties in osteosarcoma patients

Biochem Cell Biol. 2023 Oct 1;101(5):456-463. doi: 10.1139/bcb-2022-0179. Epub 2023 May 16.

Abstract

It is critical to find efficient non-invasive prognostic factor for osteosarcoma. In this study, we demonstrated that serum protein of pro-surfactant protein B (pro-SFTPB) may be a potential diagnostic indicator in osteosarcoma. We found that serum pro-SFTPB was highly expressed in osteosarcoma patients and presented good diagnostic value to discern osteosarcoma patients from non-osteosarcoma control subjects. Serum pro-SFTPB was also significantly correlated with advanced clinical stage, distant metastasis, and shorter overall survival. In addition, serum pro-SFTPB was demonstrated to be an independent prognostic factor for osteosarcoma. Overall, our study demonstrated that serum pro-SFTPB may be a useful diagnostic factor for osteosarcoma.

Keywords: osteosarcoma; pro-SFTPB diagnosis; prognosis; survival.

MeSH terms

  • Biomarkers, Tumor
  • Bone Neoplasms* / pathology
  • Humans
  • Osteosarcoma* / pathology
  • Receptors, Fc
  • Surface-Active Agents

Substances

  • IgA receptor
  • Biomarkers, Tumor
  • Receptors, Fc
  • Surface-Active Agents